{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:12:45Z","timestamp":1777356765590,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1016\/s0304-3835(02)00318-x","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:22:27Z","timestamp":1032279747000},"page":"103-109","source":"Crossref","is-referenced-by-count":10,"title":["The gain of function of the p53 mutant Asp281Gly is dependent on its ability to form tetramers"],"prefix":"10.1016","volume":"185","author":[{"given":"Annemieke","family":"Atema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Ch\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0304-3835(02)00318-X_BIB1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G","article-title":"p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis","volume":"15","author":"Soussi","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB2","first-page":"1513","article-title":"A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerisation","volume":"7","author":"Sturzbecher","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB3","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1073\/pnas.92.19.8591","article-title":"Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA","volume":"92","author":"Balagurumoorthy","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB4","first-page":"589","article-title":"Selective loss of endogenous p21waf1\/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins","volume":"13","author":"Tarunina","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/j.1460-2075.1995.tb07027.x","article-title":"The dihedral symmetry of the p53 tetramerisation domain mandates a conformational switch upon DNA binding","volume":"14","author":"Waterman","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1006\/jmbi.1999.2738","article-title":"Cellular characterisation of p53 mutants with a single missense mutation in the beta-strand 326\u2013333 and correlation of their cellular activities with in vitro properties","volume":"288","author":"Chene","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/bbrc.1997.6216","article-title":"Oligomerisation is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells","volume":"232","author":"Ishioka","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1201974","article-title":"Characterisation of p53 oligomerisation domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members","volume":"17","author":"Lomax","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<372::AID-IJC19>3.0.CO;2-8","article-title":"Characterisation of p53 mutants identified in human tumors with a missense mutation in the tetramerisation domain","volume":"78","author":"Rollenhagen","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.onc.1202062","article-title":"Characterisation of the oligomerisation defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome","volume":"17","author":"Davison","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6","article-title":"Function, oligomerisation, and conformation of tumor-associated p53 proteins with mutated C-terminus","volume":"76","author":"Atz","year":"2000","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(91)90384-B","article-title":"Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation","volume":"65","author":"Milner","year":"1991","journal-title":"Cell"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jmbi.1998.1897","article-title":"In vitro analysis of the dominant negative effect of p53 mutants","volume":"281","author":"Chene","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.1997.1360","article-title":"In vitro structure-function analysis of the beta-strand 326\u2013333 of human p53","volume":"273","author":"Chene","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB15","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/MCB.18.7.3735","article-title":"Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain","volume":"18","author":"Frazier","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1006\/jmbi.1999.2563","article-title":"p53 mutants without a functional tetramerisation domain are not oncogenic","volume":"286","author":"Chene","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB17","series-title":"Molecular Cloning. A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/emboj\/18.6.1660","article-title":"A leucine-rich nuclear export signal in the p53 tetramerisation domain: regulation of subcellular localisation and p53 activity by NES masking","volume":"18","author":"Stommel","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0593-42","article-title":"Gain of function mutations in p53","volume":"4","author":"Dittmer","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB20","first-page":"321","article-title":"Sensitivity of anticancer drugs in Saos-2 cells transfected with mutant p53 varied with mutation point","volume":"18","author":"Wang","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/S0304-3835(02)00318-X_BIB21","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/sj.onc.1201867","article-title":"Mutant p53 protein expression interferes with p53-independent apoptotic pathways","volume":"16","author":"Li","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S0304-3835(02)00318-X_BIB22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.onc.1202314","article-title":"Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy","volume":"18","author":"Blandino","year":"1999","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438350200318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438350200318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T14:04:04Z","timestamp":1583589844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438350200318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S030438350200318X"],"URL":"https:\/\/doi.org\/10.1016\/s0304-3835(02)00318-x","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}